/cloudfront-us-east-1.images.arcpublishing.com/gray/5ORNVHIZ6FHUHL74IGLVZ6RU4Q.jpg "New York jury holds drug firm Teva liable in opioid crisis")
New York jury holds drug firm Teva liable in opioid crisis
Teva Looks Towards a Sustainable Future | AP News
Jury finds Teva Pharmaceuticals fueled opioid epidemic in New York State
Acino and Teva sign deal to complete acquisition of Mepha's ...
Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler® (fluticasone propionate and salmeterol) Inhalation Powder and ArmonAir® Digihaler® (fluticasone propionate) Inhalation Powder
Teva taps former Biogen exec Richard Francis as CEO - News
Teva CEO Schultz likely won't renew employment contract: reports
Teva Pharmaceutical reports 5% fall in Q4 2022 revenue
Teva Pharmaceuticals (@TevaUSA) / Twitter
Teva's flagship drug Austedo scores new approval at the FDA
Teva Pharmaceuticals: Making Quality Health Care Accessible
We see a stable U.S. market place for our generics, says Teva Pharma CEO
Teva Pharmaceuticals (@TevaUSA) / Twitter
Teva Announces Appointment of Richard Francis as President and CEO | Business Wire
Teva Pharmaceuticals: Our manufacturing has kept up with Covid disruptions
Earnings Preview: It's a mixed bag for Teva Pharma in Q3 | AlphaStreet
Teva Pharmaceuticals CEO on the Covid-19 vaccine rollout in Israel
Teva Pharmaceuticals (@TevaUSA) / Twitter
Teva Pharmaceuticals (@TevaUSA) / Twitter
Teva Signs an Exclusive WW License Agreement with Modag to Develop Anle138b and Sery433 for Neurodegenerative Disease
Teva Pharmaceutical meets forecasts, but 2023 outlook disappoints | Reuters
Teva, with a $4.25B opioid settlement in hand, eyes return to growth by 2027 | Fierce Pharma
Teva Tries to Put an End to the Opioid Wars - WSJ
